CN110916034A - Fruit juice for purifying blood and promoting metabolism and preparation method thereof - Google Patents
Fruit juice for purifying blood and promoting metabolism and preparation method thereof Download PDFInfo
- Publication number
- CN110916034A CN110916034A CN201911107278.8A CN201911107278A CN110916034A CN 110916034 A CN110916034 A CN 110916034A CN 201911107278 A CN201911107278 A CN 201911107278A CN 110916034 A CN110916034 A CN 110916034A
- Authority
- CN
- China
- Prior art keywords
- parts
- juice
- haematococcus pluvialis
- blood
- purifying blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000004060 metabolic process Effects 0.000 title claims abstract description 24
- 210000004369 blood Anatomy 0.000 title claims abstract description 22
- 239000008280 blood Substances 0.000 title claims abstract description 22
- 230000001737 promoting effect Effects 0.000 title claims abstract description 18
- 235000015203 fruit juice Nutrition 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 69
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 32
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 24
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 23
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 21
- 102000008186 Collagen Human genes 0.000 claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 15
- 229920001436 collagen Polymers 0.000 claims abstract description 15
- 239000000230 xanthan gum Substances 0.000 claims abstract description 15
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 15
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 15
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 15
- 241000251468 Actinopterygii Species 0.000 claims abstract description 14
- 235000013557 nattō Nutrition 0.000 claims abstract description 14
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 12
- 229920001202 Inulin Polymers 0.000 claims abstract description 12
- 244000269722 Thea sinensis Species 0.000 claims abstract description 12
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 12
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 12
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 12
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 12
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 12
- 229940029339 inulin Drugs 0.000 claims abstract description 12
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 12
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 12
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 12
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 12
- 229940064064 purslane extract Drugs 0.000 claims abstract description 12
- 235000012754 curcumin Nutrition 0.000 claims abstract description 11
- 239000004148 curcumin Substances 0.000 claims abstract description 11
- 229940109262 curcumin Drugs 0.000 claims abstract description 11
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 11
- 235000009569 green tea Nutrition 0.000 claims abstract description 11
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 11
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 11
- 239000001509 sodium citrate Substances 0.000 claims abstract description 11
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 11
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 10
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 10
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 10
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 10
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims abstract description 10
- 244000302512 Momordica charantia Species 0.000 claims abstract description 10
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 10
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 10
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims abstract description 10
- 240000001890 Ribes hudsonianum Species 0.000 claims abstract description 10
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims abstract description 10
- 235000001466 Ribes nigrum Nutrition 0.000 claims abstract description 10
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims abstract description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 10
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 10
- 239000000832 lactitol Substances 0.000 claims abstract description 10
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims abstract description 10
- 229960003451 lactitol Drugs 0.000 claims abstract description 10
- 235000010448 lactitol Nutrition 0.000 claims abstract description 10
- 235000013997 pineapple juice Nutrition 0.000 claims abstract description 10
- 235000013948 strawberry juice Nutrition 0.000 claims abstract description 10
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229910000397 disodium phosphate Inorganic materials 0.000 claims abstract description 8
- 235000019800 disodium phosphate Nutrition 0.000 claims abstract description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims abstract description 4
- 244000241257 Cucumis melo Species 0.000 claims abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 239000001963 growth medium Substances 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 17
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 16
- 238000012258 culturing Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- 239000004365 Protease Substances 0.000 claims description 8
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 8
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 8
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 7
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 7
- 230000004151 fermentation Effects 0.000 claims description 7
- 235000021283 resveratrol Nutrition 0.000 claims description 7
- 229940016667 resveratrol Drugs 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 6
- 102000016942 Elastin Human genes 0.000 claims description 5
- 108010014258 Elastin Proteins 0.000 claims description 5
- 229930003270 Vitamin B Natural products 0.000 claims description 5
- 229920002549 elastin Polymers 0.000 claims description 5
- 235000019156 vitamin B Nutrition 0.000 claims description 5
- 239000011720 vitamin B Substances 0.000 claims description 5
- 108010004032 Bromelains Proteins 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 4
- 108090000526 Papain Proteins 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 235000019835 bromelain Nutrition 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- 229940106157 cellulase Drugs 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 229940087603 grape seed extract Drugs 0.000 claims description 4
- 235000002532 grape seed extract Nutrition 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 241000962514 Alosa chrysochloris Species 0.000 claims 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 abstract 1
- 229910052939 potassium sulfate Inorganic materials 0.000 abstract 1
- 235000011151 potassium sulphates Nutrition 0.000 abstract 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 abstract 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- 241000219112 Cucumis Species 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 235000013619 trace mineral Nutrition 0.000 description 6
- 239000011573 trace mineral Substances 0.000 description 6
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 5
- 241000269851 Sarda sarda Species 0.000 description 5
- 235000013793 astaxanthin Nutrition 0.000 description 5
- 239000001168 astaxanthin Substances 0.000 description 5
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 5
- 229940022405 astaxanthin Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 230000002633 protecting effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- VEVRNHHLCPGNDU-MUGJNUQGSA-N (2s)-2-amino-5-[1-[(5s)-5-amino-5-carboxypentyl]-3,5-bis[(3s)-3-amino-3-carboxypropyl]pyridin-1-ium-4-yl]pentanoate Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C([O-])=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- RNKSNIBMTUYWSH-YFKPBYRVSA-N L-prolylglycine Chemical compound [O-]C(=O)CNC(=O)[C@@H]1CCC[NH2+]1 RNKSNIBMTUYWSH-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 241000219304 Portulacaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 241001148118 Xanthomonas sp. Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002300 anti-fibrosis Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 125000001895 carotenoid group Chemical group 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- -1 diketone compound Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000000608 photoreceptor cell Anatomy 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
- A23L2/44—Preservation of non-alcoholic beverages by adding preservatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to a blood-purifying metabolism-promoting fruit juice which comprises 5-10 parts of lemon juice, 5-10 parts of strawberry juice, 6-9 parts of Hami melon juice, 3-7 parts of pineapple juice, 4-6 parts of bitter melon juice, 4-6 parts of banana juice, 3-5 parts of white gourd juice, 1-3 parts of lactitol, 1-3 parts of fructooligosaccharide, 5-10 parts of blackcurrant concentrated juice, 5-15 parts of natto freeze-dried powder, 2.8-3 parts of curcumin, 2.5-2.7 parts of grape pip extract, 2-3 parts of fish collagen peptide, 1-3 parts of green tea powder, 1.8-2 parts of purslane extract, 1.4-1.8 parts of inulin, 1.5-1.6 parts of haematococcus pluvialis, 0.08-0.12 part of L cysteine, 0.008-0.012 part of sodium citrate, 0.008-0.012 part of potassium sorbate, 0.008-0.007-0.012 part of xanthan gum, 0.008 part of nicotinic acid, 0.012-0.012 part of sodium hydrogen phosphate, 3.5-1.7 parts of sodium hydrogen phosphate, 3.012 part of bifidobacterium, 3-3 parts of sodium hydrogen sulfate, 3-3 parts of sodium hydrogen phosphate, 3 parts of potassium sulfate, 3 parts of, The balance being water. The bifidobacterium, haematococcus pluvialis and a plurality of microelements for promoting blood circulation and metabolism are added to promote metabolism of a human body, and human organs and the microelements are matched to purify blood and accelerate dirt discharge.
Description
Technical Field
The invention relates to the field of fruit juice drinks, in particular to a fruit juice capable of purifying blood and promoting metabolism and a preparation method thereof.
Background
Blood is a red opaque viscous liquid flowing in human blood vessels and heart, and consists of plasma and blood cells, wherein one liter of plasma contains 900 to 910 grams of water, 65 to 85 grams of protein and 20 grams of low molecular substances, the low molecular substances contain various electrolytes and organic compounds, and the blood cells comprise red blood cells, white blood cells and platelet cells. Blood contains various nutrients such as inorganic salts, oxygen, cellular metabolites, hormones, enzymes, antibodies, etc., and has effects of nourishing tissues, regulating organ activities, and protecting against harmful substances.
Therefore, it is necessary to develop a juice beverage which can remove toxins from the intestinal tract, liver and blood and promote metabolic circulation.
Disclosure of Invention
In order to solve the problems, the invention adopts the following technical scheme: a fruit juice for purifying blood and promoting metabolism comprises 5-10 parts of lemon juice, 5-10 parts of strawberry juice, 6-9 parts of Hami melon juice, 3-7 parts of pineapple juice, 4-6 parts of bitter melon juice, 4-6 parts of banana juice, 3-5 parts of white gourd juice, 1-3 parts of lactitol and 1-3 parts of fructo-oligosaccharide, 5-10 parts of blackcurrant concentrated juice, 5-15 parts of natto freeze-dried powder, 2.8-3 parts of curcumin, 2.5-2.7 parts of grape pip extract, 2-3 parts of fish collagen peptide, 1-3 parts of green tea powder, 1.8-2 parts of purslane extract, 1.4-1.8 parts of inulin, 1.5-1.6 parts of haematococcus pluvialis, 0.08-0.12 part of L-cysteine, 0.008-0.012 part of sodium citrate, 0.008-0.012 part of potassium sorbate, 0.008-0.012 part of xanthan gum, 0.008-0.012 part of nicotinic acid, 0.007-0.015 part of dipotassium hydrogen phosphate, 1-3 parts of sodium chloride, 0.4-0.7 part of magnesium sulfate, 0.5-1.3 part of bifidobacterium and the balance of water.
Furthermore, the resveratrol in the grape seed extract is more than or equal to 100 mg/kg.
Further, the fish collagen peptide is bonito elastin peptide.
Furthermore, the alga species of the haematococcus pluvialis is FACHB-712.
A method for preparing juice for purifying blood and promoting metabolism comprises the following steps:
s1, fermenting and culturing bifidobacteria, namely mixing 5-10 parts of lemon juice, 5-10 parts of strawberry juice, 6-9 parts of Hami melon juice, 3-7 parts of pineapple juice, 4-6 parts of bitter melon juice, 4-6 parts of banana juice and 3-5 parts of white gourd juice to serve as a culture medium of the bifidobacteria, and adding 0.5-1.3 parts of the bifidobacteria for culturing;
s2, culturing haematococcus pluvialis, namely mixing 1-3 parts of lactitol, 1-3 parts of fructooligosaccharide, 5-10 parts of blackcurrant concentrated juice, 5-15 parts of natto freeze-dried powder, 2.8-3 parts of curcumin, 2.5-2.7 parts of grape pip extract, 2-3 parts of fish collagen peptide, 1-3 parts of green tea powder, 1.8-2 parts of purslane extract, 1.4-1.8 parts of inulin, 0.08-0.12 part of L-cysteine, 0.008-0.012 part of sodium citrate, 0.008-0.012 part of potassium sorbate, 0.008-0.012 part of xanthan gum, 0.008-0.012 part of nicotinic acid, 0.007-0.015 part of dipotassium hydrogen phosphate, 1-3 parts of sodium chloride, 0.4-0.7 part of magnesium sulfate and 1-4 parts of vitamin B as a haematococcus pluvialis culture medium, and placing 1.5-1.6 parts of haematococcus pluvialis for culturing;
s3, performing enzymolysis, namely adding papain with the final concentration of 0.55 wt% into the culture medium of the bifidobacterium in the step S1, adding bromelain with the final concentration of 0.35 wt% and cellulase with the final concentration of 0.45 wt% for enzymolysis; s4, blending, namely blending the mixed solution generated in the step S2 with the mixed solution generated in the step S3;
s5, reducing acid, adding calcium carbonate to adjust the pH of the culture medium to 3.0-4.0;
s6, homogenizing the fermentation liquor after deacidification, and filtering through a 300-mesh plate frame to obtain the fruit juice.
Further, in the step S1, the culture temperature of the Bacillus dicentrus is 40-45 ℃, the stirring speed is 60-80 r/min, and the culture time is 60-72 h.
Further, in the step S2, the culture temperature of haematococcus pluvialis is 20-22 ℃, the stirring speed is 1-2 r/h, and the culture time is 60-72 h.
Further, the enzymolysis temperature in the step S3 is 55-60 ℃, and the enzymolysis time is 5 hours.
The working principle of the invention is as follows: bifidobacteria and haematococcus pluvialis are used as main gain microorganisms of the fruit juice. Can promote metabolism and purify blood.
The bifidobacteria can produce lactic acid and acetic acid after being fermented in the intestines of a human body, can improve the utilization rate of calcium, phosphorus and iron, has the functions of treating chronic diarrhea, treating constipation, protecting the liver, preventing and treating cardiovascular diseases, improving lactose digestion and the like, and can realize the enrichment of various fruit juice nutrient components by combining with later-stage enzymolysis treatment, particularly obviously improving the contents of vitamins, amino acids and trace elements.
Haematococcus pluvialis is a kind of freshwater cell green alga which can accumulate a large amount of astaxanthin to show red color, so called Haematococcus pluvialis, also called Haematococcus pluvialis, which is a kind of alga food found in the current scientific community after Spirulina and Chlorella and is rich in nutritive value and medicinal value, the content of astaxanthin in Haematococcus pluvialis is 1.5% -10.0%, which is regarded as a natural astaxanthin "concentrate", and astaxanthin is one of carotenoid group, the highest-order product of carotenoid synthesis, β -carotene, lutein, canthaxanthin, lycopene, etc. are intermediate products of carotenoid synthesis, so that astaxanthin has strong oxidation resistance in nature, and it can effectively prevent retinal oxidation and photoreceptor cell damage through blood brain barrier and cell membrane, and protect the central nervous system, especially the brain, thus effectively treating ischemia-reperfusion injury, Parkinson's syndrome, Alzheimer's syndrome, etc. in particular, the effects of macular degeneration are more remarkable than those of lutein, and the effects of the central nervous system, protecting the eye, preventing cardiovascular diseases, preventing fatigue, preventing cardiovascular diseases, and preventing diseases.
L-cysteine weakens the protein structure by changing disulfide bonds between and within protein molecules, so that the protein stretches.
Sodium citrate is used as an acidity regulator, a flavoring agent, a stabilizer in the food and beverage industry; in the pharmaceutical industry as anticoagulant, expectorant and diuretic.
Resveratrol is a natural polyphenol substance with strong biological property, and is also called as resveratrol. The grape skin has the highest content, and the grape seeds also contain the substance. The resveratrol has good effects of reducing platelet aggregation and preventing and treating atherosclerosis and cardiovascular and cerebrovascular diseases. The resveratrol can well pass through a blood brain barrier, and the grape seed extract has stronger antioxidant capacity and low price.
The fish collagen peptide is bonito elastin peptide. The bonito elastin peptide is extracted from heart artery tissue of deep sea bonito, retains two marker amino acids of desmosine and isodesmosine, is added effectively in sufficient amount, and is absorbed by amino acid peptide chain such as PG (prolylglycine) decomposed by human body, and has synergistic effect with collagen peptide, and is helpful for enhancing blood vessel elasticity and relieving blood vessel aging.
The natto freeze-dried powder is solid fermented natto, is frozen at minus 40 ℃, is subjected to vacuum dehumidification, sublimation drying and crushing to form the natto freeze-dried powder, retains physiological active substances in the natto to the maximum extent, is beneficial to dissolving thrombus, repairing damaged blood cells and blood vessel cells, and effectively improves coronary heart disease, hypertension, arteriosclerosis, stroke and varicosity.
Curcumin is a diketone compound extracted from rhizomes of plants in Zingiberaceae and Araceae, and Curcuma rhizome contains 3-6%, and has antiinflammatory, antioxidant, oxygen free radical scavenging, anti-HIV, liver and kidney protecting, anti-fibrosis, and anticancer effects.
The green tea powder has good antioxidant and tranquilizing effects, can relieve fatigue, contains vitamin C and flavonoid, wherein the flavonoid can enhance the antioxidant effect of vitamin C, is beneficial to maintaining skin whitening, relieving constipation, slimming and beautifying, and has promoting effect on losing weight.
The purslane extract is extracted from stems and leaves of purslane by a low-temperature method to obtain the extract with bioactivity, the purslane extract can induce diuresis to alleviate edema, contains a large amount of potassium salts, can directly act on blood vessels of human beings to promote vasodilatation and accelerate blood circulation, and meanwhile, the trace element potassium can promote sodium salt metabolism in human bodies and can prevent hypertension.
Inulin molecules are polymerized by 31 β -D-fructofuranose and 1-2 pyranose inulin residues, can improve hyperlipidemia, and can generate a large amount of short-chain fatty acids in the fermentation process of prebiotics and bacteria in intestinal tracts contained in the inulin to help people to improve blood lipid and promote metabolism of human bodies.
The potassium sorbate can effectively inhibit the activity of mould, microzyme and aerobic bacteria and prevent the growth and reproduction of harmful microorganisms such as botulium, staphylococcus and salmonella, but has little effect on beneficial microorganisms such as anaerobic bacillus and lactobacillus acidophilus, and the effect of inhibiting the development of the potassium sorbate is stronger than the sterilization effect, thereby effectively prolonging the preservation time of the food and keeping the flavor of the original food. The antiseptic effect is 5-10 times of that of sodium benzoate of the same kind of product.
Xanthan gum is also known as xanthan gum and xanthan gum, and is an extracellular microorganism multi-pond produced by fermenting saccharides with xanthomonas sp. Due to the special structure and colloid characteristics of its macromolecules, it has multiple functions, and can be used as emulsifier, stabilizer and gel thickener.
Niacin is also known as vitamin B3 and vitamin PP. In human body, also includes its derivative, ammonia hydrochloride or nicotinamide, which is one of 13 vitamins essential for human body, is a water-soluble vitamin, and belongs to vitamin B group. Nicotinic acid is converted into nicotinamide in human body, is a coenzyme and a component of the coenzyme, and is involved in the metabolic tissue of lipid in vivo, the oxidation process of respiration and the anaerobic decomposition process of saccharides.
Dipotassium hydrogen phosphate is used in the food industry as a raw material for preparing alkaline water for pasta, a fermentation agent, a flavoring agent, a leavening agent, a mild alkaline agent for dairy products, and yeast food, and is sometimes added to milk tea powder.
The sodium chloride is edible salt.
Magnesium sulfate is the main component of the medical diarrhea medicine, and can promote the metabolism of a human body when being taken in a trace amount.
The invention has the beneficial effects that: the addition of the bifidobacteria, the haematococcus pluvialis and various trace elements for promoting blood circulation and metabolism can promote metabolism of a human body, and meanwhile, metabolic organs such as blood vessels, livers, kidneys and the like are maintained, so that the human organs and the trace elements are matched to purify blood, and metabolism is accelerated to discharge dirt.
Detailed Description
The fruit juice capable of purifying blood and promoting metabolism provided by one embodiment of the invention comprises 5-10 parts of lemon juice, 5-10 parts of strawberry juice, 6-9 parts of Hami melon juice, 3-7 parts of pineapple juice, 4-6 parts of bitter melon juice, 4-6 parts of banana juice, 3-5 parts of white gourd juice, 1-3 parts of lactitol, 1-3 parts of fructooligosaccharide, 5-10 parts of blackcurrant concentrated juice, 5-15 parts of natto freeze-dried powder, 2.8-3 parts of curcumin, 2.5-2.7 parts of grape pip extract, 2-3 parts of fish collagen peptide, 1-3 parts of green tea powder, 1.8-2 parts of purslane extract, 1.4-1.8 parts of inulin, 1.5-1.6 parts of haematococcus pluvialis, 0.08-0.12 part of L-cysteine, 0.008-0.012 part of sodium citrate, 0.008-0.012 part of potassium sorbate, 0.008-0.007 part of nicotinic acid, 0.015 part of xanthan gum, 0.012-0.012 part of sodium hydrogen phosphate, 3.012 part of sodium chloride, 3.012-0.012 part of xanthan gum, 3.012 part of sodium hydrogen phosphate, 3.5-0.7 parts of sodium hydrogen phosphate, 3 parts of xanthan gum, The balance being water.
Furthermore, the resveratrol in the grape seed extract is more than or equal to 100 mg/kg.
Further, the fish collagen peptide is bonito elastin peptide.
Furthermore, the alga species of the haematococcus pluvialis is FACHB-712.
A method for preparing juice for purifying blood and promoting metabolism comprises the following steps:
s1, fermenting and culturing bifidobacteria, namely mixing 5-10 parts of lemon juice, 5-10 parts of strawberry juice, 6-9 parts of Hami melon juice, 3-7 parts of pineapple juice, 4-6 parts of bitter melon juice, 4-6 parts of banana juice and 3-5 parts of white gourd juice to serve as a culture medium of the bifidobacteria, and adding 0.5-1.3 parts of the bifidobacteria for culturing;
s2, culturing haematococcus pluvialis, namely mixing 1-3 parts of lactitol, 1-3 parts of fructooligosaccharide, 5-10 parts of blackcurrant concentrated juice, 5-15 parts of natto freeze-dried powder, 2.8-3 parts of curcumin, 2.5-2.7 parts of grape pip extract, 2-3 parts of fish collagen peptide, 1-3 parts of green tea powder, 1.8-2 parts of purslane extract, 1.4-1.8 parts of inulin, 0.08-0.12 part of L-cysteine, 0.008-0.012 part of sodium citrate, 0.008-0.012 part of potassium sorbate, 0.008-0.012 part of xanthan gum, 0.008-0.012 part of nicotinic acid, 0.007-0.015 part of dipotassium hydrogen phosphate, 1-3 parts of sodium chloride, 0.4-0.7 part of magnesium sulfate and 1-4 parts of vitamin B as a haematococcus pluvialis culture medium, and placing 1.5-1.6 parts of haematococcus pluvialis for culturing;
s3, performing enzymolysis, namely adding papain with the final concentration of 0.55 wt% into the culture medium of the bifidobacterium in the step S1, adding bromelain with the final concentration of 0.35 wt% and cellulase with the final concentration of 0.45 wt% for enzymolysis;
s4, blending, namely blending the mixed solution generated in the step S2 with the mixed solution generated in the step S3;
s5, reducing acid, adding calcium carbonate to adjust the pH of the culture medium to 3.0-4.0;
s6, homogenizing the fermentation liquor after deacidification, and filtering through a 300-mesh plate frame to obtain the fruit juice.
Further, in the step S1, the culture temperature of the Bacillus dicentrus is 40-45 ℃, the stirring speed is 60-80 r/min, and the culture time is 60-72 h.
Further, in the step S2, the culture temperature of haematococcus pluvialis is 20-22 ℃, the stirring speed is 1-2 r/h, and the culture time is 60-72 h.
Further, the enzymolysis temperature in the step S3 is 55-60 ℃, and the enzymolysis time is 5 hours.
Example 1:
7 parts of lemon juice, 7 parts of strawberry juice, 8 parts of Hami melon juice, 5 parts of pineapple juice, 5 parts of bitter melon juice, 5 parts of banana juice, 4 parts of white gourd juice, 2 parts of lactitol, 2 parts of fructooligosaccharide, 5 parts of blackcurrant concentrated juice, 5 parts of natto freeze-dried powder, 2.8 parts of curcumin, 2.5 parts of grape pip extract, 2 parts of fish collagen peptide, 1 part of green tea powder, 1.8 parts of purslane extract, 1.4 parts of inulin, 1.5 parts of haematococcus pluvialis, 0.12 part of L-cysteine, 0.012 part of sodium citrate, 0.012 part of potassium sorbate, 0.012 part of xanthan gum, 0.012 part of nicotinic acid, 0.015 part of dipotassium hydrogen phosphate, 3 parts of sodium chloride, 0.7 part of magnesium sulfate, 1.3 parts of bifidobacterium and the balance of water of 26.817 parts. The trace elements have high specific gravity, and the functions of purifying blood and promoting metabolism are stronger.
Example 2:
the beverage comprises 9 parts of lemon juice, 9 parts of strawberry juice, 8 parts of Hami melon juice, 6 parts of pineapple juice, 6 parts of bitter melon juice, 6 parts of banana juice, 5 parts of white gourd juice, 1 part of lactitol, 1 part of fructooligosaccharide, 5 parts of blackcurrant concentrated juice, 5 parts of natto freeze-dried powder, 2.8 parts of curcumin, 2.5 parts of grape pip extract, 2 parts of fish collagen peptide, 3 parts of green tea powder, 2 parts of purslane extract, 1.4 parts of inulin, 1.6 parts of haematococcus pluvialis, 0.08 part of L-cysteine, 0.008 part of sodium citrate, 0.008 part of potassium sorbate, 0.008 part of xanthan gum, 0.008 part of nicotinic acid, 0.007 part of dipotassium hydrogen phosphate, 1 part of sodium chloride, 0.4 part of magnesium sulfate, 0.5 part of bifidobacterium and the balance of 21.681 parts of water. The trace elements have a low specific gravity and are suitable for use by the wakened person.
Example 3:
firstly, fermenting and culturing bifidobacterium, namely mixing 9 parts of lemon juice, 9 parts of strawberry juice, 8 parts of Hami melon juice, 6 parts of pineapple juice, 6 parts of bitter melon juice, 6 parts of banana juice and 5 parts of white gourd juice to serve as a culture medium of the bifidobacterium, and adding 0.5 part of the bifidobacterium for culturing at the temperature of 45 ℃ at the stirring speed of 80r/min for 60 hours.
And secondly, culturing haematococcus pluvialis, namely mixing 1 part of lactitol, 1 part of fructooligosaccharide, 5 parts of blackcurrant concentrated juice, 5 parts of natto freeze-dried powder, 2.8 parts of curcumin, 2.5 parts of grape pip extract, 2 parts of fish collagen peptide, 3 parts of green tea powder, 2 parts of purslane extract, 1.4 parts of inulin, 0.08 part of L-cysteine, 0.008 part of sodium citrate, 0.008 part of potassium sorbate, 0.008 part of xanthan gum, 0.008 part of nicotinic acid, 0.007 part of dipotassium hydrogen phosphate, 1 part of sodium chloride, 0.4 part of magnesium sulfate and 4 parts of vitamin B to obtain a haematococcus pluvialis culture medium, and putting 1.5 parts of haematococcus pluvialis for culturing at the culture temperature of 22 ℃, at the stirring speed of 2r/h and for 60 h.
Thirdly, enzymolysis, namely adding papain with the final concentration of 0.55 wt%, bromelain with the final concentration of 0.35 wt% and cellulase with the final concentration of 0.45 wt% into a culture medium of bifidobacterium for enzymolysis, wherein the enzymolysis temperature is 55 ℃, and the enzymolysis time is 5 hours;
fourthly, blending, namely blending and mixing the bifidobacterium culture medium and the haematococcus pluvialis culture medium;
fifthly, reducing acid, adding calcium carbonate to adjust the pH value of the culture medium to 4.0;
and step six, homogenizing, namely homogenizing the fermentation liquor subjected to deacidification, and filtering the fermentation liquor through a 300-mesh plate frame to obtain the fruit juice.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Claims (8)
1. A fruit juice for purifying blood and promoting metabolism, which is characterized in that: the beverage comprises 5-10 parts of lemon juice, 5-10 parts of strawberry juice, 6-9 parts of Hami melon juice, 3-7 parts of pineapple juice, 4-6 parts of bitter melon juice, 4-6 parts of banana juice, 3-5 parts of white gourd juice, 1-3 parts of lactitol, 1-3 parts of fructooligosaccharide, 5-10 parts of blackcurrant concentrated juice, 5-15 parts of natto freeze-dried powder, 2.8-3 parts of curcumin, 2.5-2.7 parts of grape pip extract, 2-3 parts of fish collagen peptide, 1-3 parts of green tea powder, 1.8-2 parts of purslane extract, 1.4-1.8 parts of inulin, 1.5-1.6 parts of haematococcus pluvialis, 0.08-0.12 part of L cysteine, 0.008-0.012 part of sodium citrate, 0.008-0.012 part of potassium sorbate, 0.008-0.012 part of sodium hydrogen phosphate, 0.015-0.7 part of sodium sulfate, 3.7-3 parts of sodium hydrogen phosphate and the balance of xanthan gum.
2. The juice for purifying blood and promoting metabolism according to claim 1, wherein: the resveratrol in the grape seed extract is more than or equal to 100 mg/kg.
3. The juice for purifying blood and promoting metabolism according to claim 1, wherein: the fish collagen peptide is skipjack elastin peptide.
4. The juice for purifying blood and promoting metabolism according to claim 1, wherein: the Haematococcus pluvialis strain is FACHB-712.
5. A method for preparing a blood-purifying metabolism-promoting fruit juice according to claims 1 to 4, comprising the steps of:
s1, fermenting and culturing bifidobacteria, namely mixing 5-10 parts of lemon juice, 5-10 parts of strawberry juice, 6-9 parts of Hami melon juice, 3-7 parts of pineapple juice, 4-6 parts of bitter melon juice, 4-6 parts of banana juice and 3-5 parts of white gourd juice to serve as a culture medium of the bifidobacteria, and adding 0.5-1.3 parts of the bifidobacteria for culturing;
s2, culturing haematococcus pluvialis, namely mixing 1-3 parts of lactitol, 1-3 parts of fructooligosaccharide, 5-10 parts of blackcurrant concentrated juice, 5-15 parts of natto freeze-dried powder, 2.8-3 parts of curcumin, 2.5-2.7 parts of grape pip extract, 2-3 parts of fish collagen peptide, 1-3 parts of green tea powder, 1.8-2 parts of purslane extract, 1.4-1.8 parts of inulin, 0.08-0.12 part of L-cysteine, 0.008-0.012 part of sodium citrate, 0.008-0.012 part of potassium sorbate, 0.008-0.012 part of xanthan gum, 0.008-0.012 part of nicotinic acid, 0.007-0.015 part of dipotassium hydrogen phosphate, 1-3 parts of sodium chloride, 0.4-0.7 part of magnesium sulfate and 1-4 parts of vitamin B as a haematococcus pluvialis culture medium, and placing 1.5-1.6 parts of haematococcus pluvialis for culturing;
s3, performing enzymolysis, namely adding papain with the final concentration of 0.55 wt% into the culture medium of the bifidobacterium in the step S1, adding bromelain with the final concentration of 0.35 wt% and cellulase with the final concentration of 0.45 wt% for enzymolysis;
s4, blending, namely blending the mixed solution generated in the step S2 with the mixed solution generated in the step S3;
s5, reducing acid, adding calcium carbonate to adjust the pH of the culture medium to 3.0-4.0;
s6, homogenizing the fermentation liquor after deacidification, and filtering through a 300-mesh plate frame to obtain the fruit juice.
6. The method for preparing juice for purifying blood and promoting metabolism according to claim 5, wherein: in the step S1, the culture temperature of the Bacillus dicentrus is 40-45 ℃, the stirring speed is 60-80 r/min, and the culture time is 60-72 h.
7. The method for preparing juice for purifying blood and promoting metabolism according to claim 5, wherein: in the step S2, the culture temperature of haematococcus pluvialis is 20-22 ℃, the stirring speed is 1-2 r/h, and the culture time is 60-72 h.
8. The method for preparing juice for purifying blood and promoting metabolism according to claim 5, wherein: and in the step S3, the enzymolysis temperature is 55-60 ℃, and the enzymolysis time is 5 h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911107278.8A CN110916034A (en) | 2019-11-13 | 2019-11-13 | Fruit juice for purifying blood and promoting metabolism and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911107278.8A CN110916034A (en) | 2019-11-13 | 2019-11-13 | Fruit juice for purifying blood and promoting metabolism and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110916034A true CN110916034A (en) | 2020-03-27 |
Family
ID=69852880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911107278.8A Withdrawn CN110916034A (en) | 2019-11-13 | 2019-11-13 | Fruit juice for purifying blood and promoting metabolism and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110916034A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111513321A (en) * | 2020-05-18 | 2020-08-11 | 周旋 | Health oral liquid prepared from Prunus davidiana var as main raw material |
-
2019
- 2019-11-13 CN CN201911107278.8A patent/CN110916034A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111513321A (en) * | 2020-05-18 | 2020-08-11 | 周旋 | Health oral liquid prepared from Prunus davidiana var as main raw material |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Beheshtipour et al. | Supplementation of Spirulina platensis and Chlorella vulgaris algae into probiotic fermented milks | |
CN106135977B (en) | Production method of calcium fruit powder with functions of supplementing calcium and improving eyesight | |
CN108783431A (en) | A kind of fruit ferment and preparation method thereof | |
CN105614858A (en) | Plant ferment product and preparation thereof | |
CN111480850A (en) | Haematococcus pluvialis and collagen protein beverage | |
KR20160058389A (en) | Method of Manufacturing Volumizing Antocyanine Probiotics Metabolite and Pharmetics, cosmetics and Juice and food complex | |
CN106376917A (en) | Health food or drink formula for regulating emotions from multiple aspects | |
CN107183457A (en) | A kind of probiotic fruit juice beverage and preparation method thereof | |
CN107712537A (en) | A kind of lutein ester solid beverage | |
CN104664515A (en) | Blueberry coarse cereal-fermented beverage and preparation method thereof | |
CN104382129A (en) | Beverage prepared from sweet corn and black tea fungus | |
CN110279048A (en) | A kind of composite fruit juice function factor beverage and preparation method thereof | |
JP2006075086A (en) | Fermented product obtained from papaya | |
CN110916034A (en) | Fruit juice for purifying blood and promoting metabolism and preparation method thereof | |
JP2005312424A (en) | Method for producing fermented product using kefir grain, and fermented product obtained by the same | |
CN104287044A (en) | Kiwi fruit and red tea fungus drink | |
CN104304561A (en) | Phellinus mycelium and tea fungus beverage | |
CN104305429A (en) | Fermentation type okra tea drink | |
CN1456097A (en) | Functional marine food and producing method thereof | |
JP2018145161A (en) | Composition for inhibiting elevation of blood pressure and method for producing the same | |
CN104273611A (en) | Tomato tea fungus beverage | |
JP2009240308A (en) | METHOD FOR PRODUCING MATERIAL CONTAINING Gamma-AMINOBUTYRIC ACID IN HIGH CONTENT | |
JP2006089408A (en) | Fermented product obtained from lemon | |
CN104381442A (en) | Anti-aging health-care yogurt capable of cleansing intestines, rejuvenating skin and keeping beauty and production method thereof | |
CN105212226B (en) | A kind of proline nutrition enhancer and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200327 |